Renal Demo 1 Renal Metastases Demo TexRAD: Potential predictive imaging biomarker of response to treatment in metastatic r...
Renal Demo 2 Renal Metastases Demo TexRAD: Potential predictive imaging biomarker of response to treatment in metastatic r...
Renal Evidence 1 Renal Early Evidence Clinical Evidence – Recent findings a ccepted in ECR 2010 [1]   Case Study  |  Demo ...
Renal Evidence 2 Renal Early Evidence Clinical Evidence – Recent findings a ccepted in ECR 2010 [1]  Case Study  |  Demo  ...
References - Renal <ul><li>RENAL </li></ul><ul><li>1   Ganeshan B, Rajpopat M, Vinayan A, Nathan P, Goh V, Miles KA. CT te...
Upcoming SlideShare
Loading in …5
×

TexRAD Renal Cancer

799 views
745 views

Published on

TexRAD is a software application that analyses the textures in existing radiological scans to assist the clinician in assessing the prognosis of patients with cancer

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
799
On SlideShare
0
From Embeds
0
Number of Embeds
4
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

TexRAD Renal Cancer

  1. 1. Renal Demo 1 Renal Metastases Demo TexRAD: Potential predictive imaging biomarker of response to treatment in metastatic renal cancer TexRAD PRE-TREATMENT Case Study | Demo | Evidence Screenshot of the Renal TexRAD highlighting ‘Right lobe liver’ metastases (pre-treatment) on the conventional CT image (top-left), followed by the derived texture maps superimposed on the conventional CT image – fine (red), medium (green) and coarse (blue) texture 5 6 6 7 8 1 2 3 4
  2. 2. Renal Demo 2 Renal Metastases Demo TexRAD: Potential predictive imaging biomarker of response to treatment in metastatic renal cancer TexRAD POST-TREATMENT Case Study | Demo | Evidence Screenshot of the Renal TexRAD highlighting ‘Right lobe liver’ metastases (post-treatment) on the conventional CT image (top-left), followed by the derived texture maps superimposed on the conventional CT image – fine (red), medium (green) and coarse (blue) texture 5 6 6 7 8 1 2 3 4
  3. 3. Renal Evidence 1 Renal Early Evidence Clinical Evidence – Recent findings a ccepted in ECR 2010 [1] Case Study | Demo | Evidence CT Texture significantly predicts patients with poor prognosis (treatment response) 5 6 6 7 8 1 2 3 4 p < 0.005
  4. 4. Renal Evidence 2 Renal Early Evidence Clinical Evidence – Recent findings a ccepted in ECR 2010 [1] Case Study | Demo | Evidence Existing anatomical imaging response criteria (RECIST) did not significantly predict patients with poor prognosis 5 6 6 7 8 1 2 3 4
  5. 5. References - Renal <ul><li>RENAL </li></ul><ul><li>1 Ganeshan B, Rajpopat M, Vinayan A, Nathan P, Goh V, Miles KA. CT texture and enhancement: Potential predictive imaging biomarkers of response to treatment in metastatic renal cancer. Accepted as a paper presentation in European Society of Radiology 2010, Vienna, Austria. </li></ul>References - Renal Cancer Colorectal | Lung | Breast | Prostate | Renal | Lung | Brain | DTA

×